Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2004
09/15/2004EP1455779A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/15/2004EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1455771A2 2-indanylamino derivatives for the therapy of chronic pain
09/15/2004EP1455770A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
09/15/2004EP1455759A2 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
09/15/2004EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
09/15/2004EP1455602A1 Modified methionine rich food products and process for their manufacture
09/15/2004EP1370547B1 Benzoaxathiepin derivatives and their use as medicines
09/15/2004EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
09/15/2004EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
09/15/2004EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
09/15/2004EP1133487B1 Antioxidants
09/15/2004EP1133467B1 Ion channel modulating agents
09/15/2004EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives
09/15/2004EP1001814B1 Controlled release microencapsulated ngf formulation
09/15/2004EP0877760B1 Mhc complexes and uses thereof
09/15/2004EP0862423B1 Pharmaceutical composition for oral administration
09/15/2004EP0841937B1 Use of betaglycan to reduce scarring
09/15/2004EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases
09/15/2004EP0680327B1 Therapeutic uses and delivery systems of dehydroepiandrosterone
09/15/2004CN1529706A 哌嗪衍生物 Piperazine derivatives
09/15/2004CN1529705A Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
09/15/2004CN1529703A 新的吲哚衍生物 The new indole derivatives
09/15/2004CN1529701A Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof
09/15/2004CN1529697A Tricyclic compounds useful as angiotensin II agonists
09/15/2004CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays
09/15/2004CN1529614A Method of reducing side effects of chemotherapy in cancer patient
09/15/2004CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells
09/15/2004CN1529610A Remedies
09/15/2004CN1529606A Preparation containing seleniter or selenate for treating wound
09/15/2004CN1529600A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses
09/15/2004CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage
09/15/2004CN1529598A Method of treating demyelinating diseases or conditions
09/15/2004CN1529597A Imidazo (1,2-A)_pyridine derivatives as mGLUR5 antagonists
09/15/2004CN1529596A Utilization of benzdihydro-pyrane
09/15/2004CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic
09/15/2004CN1528767A Chinese medicine gelsmium elegans total alkaloid for anticancer and analgesia, and medicinal composition containing it and preparing method thereof
09/15/2004CN1528753A Morpholol with medicinal activity
09/15/2004CN1528433A Method for extracting active rpinciple for analgesia from fillworm using water
09/15/2004CN1528426A Soft capsule and preparing method thereof
09/15/2004CN1528424A Soft capsule and preparing method thereof
09/15/2004CN1528403A Medicine for treating headache and preparing method thereof
09/15/2004CN1528402A Tonic soporific liquid
09/15/2004CN1528400A Oral liquid for treating deuteropathic weak and senile weak
09/15/2004CN1528387A Use of radix rhodiolae for preparing medicine for treating or preventing senile dementia
09/15/2004CN1528379A Method for preparing full rhizoma gastrodiae cell rupture micro-pill capsule
09/15/2004CN1528369A Medicine for treating kidney and spleen and preparing method thereof
09/15/2004CN1528366A Semen strychni-lumbricus ointment for relieving pain
09/15/2004CN1528364A Lumbricus-bungarus seu agkistrodon capsule for activating meridians and stopping pain and preparing method thereof
09/15/2004CN1528321A Rhizoma gastrodiae extract drop pill and preparing method thereof
09/15/2004CN1528320A Acetyl rhizoma gastrodiae extract drop pill and preparing method thereof
09/15/2004CN1528315A Method for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists
09/15/2004CN1528304A Anisodine hydrobromide drop pill and preparing method thereof
09/15/2004CN1528298A Isocarboxazid drop pill and preparing method thereof
09/15/2004CN1528276A Method for treating cephalagra
09/15/2004CN1528275A Fluoxetine hydrochloride drop pill and preparing method thereof
09/15/2004CN1528227A Gold brain-care pillow pad and making method thereof
09/15/2004CN1166678C Purine derivatives
09/15/2004CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
09/15/2004CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
09/15/2004CN1166643C 4-phenyl-pyrimidine derivatives
09/15/2004CN1166641C New cycloheplene compound, its preparation method and medicine composition containing same
09/15/2004CN1166640C Substituted 1,2,3,4,5,6-hyxahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
09/15/2004CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
09/15/2004CN1166636C Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
09/15/2004CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
09/15/2004CN1166622C 2-amino-1, 2-hydrindene as selective dopamine D3 ligands
09/15/2004CN1166391C Anti-drunk-enness and sobering up composition and its preparing method
09/15/2004CN1166374C Hemiplegia treating pill
09/15/2004CN1166360C Long acting injection microsphere combination of naltrexone, its preparation method and application
09/14/2004US6791003 Dual adhesive transdermal drug delivery system
09/14/2004US6790992 Scyphostatin analogues as SMase inhibitors
09/14/2004US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury
09/14/2004US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction
09/14/2004US6790953 Ether compounds
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered
09/14/2004US6790854 Diphenylalkylamine derivatives useful as opioid receptor agonists
09/14/2004US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity
09/14/2004US6790826 Human haemopoietic maturation factor
09/14/2004US6790825 Stimulating secretion of pancreatic juices
09/14/2004US6790824 Cytokines having neurotrophic activity
09/14/2004US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments
09/14/2004US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes
09/14/2004US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions
09/14/2004US6790447 Peptides for treatment of autoimmune diseases
09/14/2004US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts
09/14/2004CA2274389C Paroxetine tablets and process to prepare them
09/14/2004CA2264549C Spirocyclic dopamine receptor subtype ligands
09/14/2004CA2130115C Prevention of retinal injury and degeneration by specific factors
09/10/2004WO2004077055A1 Method of detecting onset risk of encephalitis or encephalopathy
09/10/2004WO2004076667A1 Double-strand rna oligonucleotide having effect of inhibiting the expression of cyclin b gene
09/10/2004WO2004076478A1 PEPTIDE DERIVATIVES HAVING β-SECRETASE INHIBITORY ACTIVITY
09/10/2004WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator
09/10/2004WO2004076453A1 Novel diazabicyclic aryl derivatives
09/10/2004WO2004076452A1 5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION
09/10/2004WO2004075916A1 Pharmaceutical composition for treatment of drug dependence
09/10/2004WO2004075902A1 Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder
09/10/2004WO2004075897A1 Pten inhibitor or maxi-k channels opener